美邦股份:光大证券股份有限公司关于陕西美邦药业集团股份有限公司部分募投项目结项并将节余募集资金永久补充流动资金的核查意见2024-12-14
2
2021 2738
A 3,380
1.00 12.69 /
428,922,000.00 37,078,608.07
391,843,391.93
2021 9 8 2021 230Z0192
2
1
2021 9
801011580000354751 78550180808090089 129910070810555 81
11701012300647488 26530101040031754 2021 11
7855018080180
0095
2024 12 10
801011580000354751 3,662.01
78550180808090089 0.15
129910070810555 0.00
8111701012300647488 1,785.29
26530101040031754 0.00
78550180801800095 1,325.64
- 6,773.09
(
2024 12
1 15,259.91 10,284.34
2024 12
2 7,370.00 7,000.00
2024 12
3 8,268.28 4,300.00
2025 12
4 3,279.18 3,000.00
5 14,600.00 14,600.00 -
48,777.37 39,184.34 -
2024
12 10
10,284.34 6,958.21 335.87 3,662.01
7,000.00 5,866.10 191.90 1,325.79
4,300.00 4,373.36 73.36 0.00
21,584.34 17,197.67 601.13 4,987.80
1
2
3
4,987.80
2024 12 13
2024 12 13
2024
2
1